Survey of resistance of herpes simplex virus to acyclovir in northwest England.

PubWeight™: 1.89‹?› | Rank: Top 3%

🔗 View Article (PMC 105557)

Published in Antimicrob Agents Chemother on April 01, 1998

Authors

J Christophers1, J Clayton, J Craske, R Ward, P Collins, M Trowbridge, G Darby

Author Affiliations

1: Manchester Public Health Laboratory, Withington Hospital, United Kingdom.

Articles citing this

Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol (2012) 2.78

Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev (2003) 1.95

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother (2010) 1.73

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol (2004) 1.56

Recent advances in management of genital herpes. Can Fam Physician (2000) 1.44

Novel class of thiourea compounds that inhibit herpes simplex virus type 1 DNA cleavage and encapsidation: resistance maps to the UL6 gene. J Virol (2000) 1.30

Screening for antiviral activities of isolated compounds from essential oils. Evid Based Complement Alternat Med (2011) 1.18

Difference in incidence of spontaneous mutations between Herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2000) 1.09

Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res (2009) 1.09

Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir. J Virol (2001) 1.09

High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant. J Virol (2003) 1.05

Translational compensation of a frameshift mutation affecting herpes simplex virus thymidine kinase is sufficient to permit reactivation from latency. J Virol (2003) 1.04

Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J Virol (2001) 1.00

Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase. J Virol (2006) 0.97

Acyclovir resistance in herpes simplex virus type I encephalitis: a case report. J Neurovirol (2016) 0.97

Immune responses and the emergence of drug-resistant virus strains in vivo. Proc Biol Sci (2004) 0.96

Susceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood. Antimicrob Agents Chemother (2007) 0.90

Herpes simplex virus thymidine kinase mutations associated with resistance to acyclovir: a site-directed mutagenesis study. Antimicrob Agents Chemother (2005) 0.90

Antiviral selection in the management of acute retinal necrosis. Clin Ophthalmol (2010) 0.88

Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol (2010) 0.88

Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. J Clin Microbiol (2001) 0.87

Application of real-time PCR for determination of antiviral drug susceptibility of herpes simplex virus. Antimicrob Agents Chemother (2002) 0.87

Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis. Antimicrob Agents Chemother (2002) 0.86

Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin. J Virol (2005) 0.86

Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance. Drug Resist Updat (2011) 0.86

Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance. Antimicrob Agents Chemother (2015) 0.85

ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing. Antimicrob Agents Chemother (2004) 0.84

Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models. Antimicrob Agents Chemother (2000) 0.83

Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am (2010) 0.82

Herpesvirus infections of the central nervous system in immunocompromised patients. Ther Adv Neurol Disord (2012) 0.81

A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame. Antimicrob Agents Chemother (2000) 0.81

Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir. Clin Diagn Lab Immunol (2002) 0.81

Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis. Antimicrob Agents Chemother (2002) 0.81

Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia. J Virol (2007) 0.81

2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2012) 0.81

Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor. Antimicrob Agents Chemother (2012) 0.80

Tranylcypromine reduces herpes simplex virus 1 infection in mice. Antimicrob Agents Chemother (2014) 0.79

Acyclovir-resistant herpetic keratitis in a solid-organ transplant recipient on systemic immunosuppression. Clin Ophthalmol (2013) 0.78

Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel? Ophthalmol Eye Dis (2012) 0.77

Development and evaluation of a host-targeted antiviral that abrogates herpes simplex virus replication through modulation of arginine-associated metabolic pathways. Antiviral Res (2016) 0.75

Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence. Virol J (2017) 0.75

Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice. J Virol (2016) 0.75

Anti-HSV activity of serpin antithrombin III. Int Trends Immun (2014) 0.75

Articles cited by this

A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus. Virology (1967) 5.22

The pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice. J Hyg (Lond) (1978) 4.07

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med (1989) 2.56

Herpes simplex virus resistant to acyclovir. A study in a tertiary care center. Ann Intern Med (1990) 2.53

The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol (1989) 2.40

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature (1981) 2.03

Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med (1993) 1.57

Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1994) 1.50

Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J Med Virol (1993) 1.35

Characterization of a DNA polymerase mutant of herpes simplex virus from a severely immunocompromised patient receiving acyclovir. J Gen Virol (1989) 1.33

Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus. Evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. J Biol Chem (1983) 1.31

Virus drug-resistance: mechanisms and consequences. Antiviral Res (1984) 1.29

Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. Antimicrob Agents Chemother (1987) 1.24

Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother (1985) 1.17

Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology (1985) 1.13

Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia. J Infect (1989) 0.97

Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. J Antimicrob Chemother (1986) 0.95

Articles by these authors

(truncated to the top 100)

GEL, a DNA sequencing project management system. Nucleic Acids Res (1982) 18.85

Linkage disequilibrium in the human genome. Nature (2001) 17.24

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science (1989) 14.63

9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature (1978) 9.21

SEQ: a nucleotide sequence analysis and recombination system. Nucleic Acids Res (1982) 8.73

Patients' action during their cardiac event: qualitative study exploring differences and modifiable factors. BMJ (1998) 7.00

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36

Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell (1988) 4.47

Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature (1987) 4.45

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis (1992) 4.21

A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet (2001) 4.17

THE ISOLATION OF POLIOMYELITIS VIRUS FROM HUMAN EXTRA-NEURAL SOURCES. III. PERSISTENCE OF VIRUS IN STOOLS AFTER ACUTE INFECTION. J Clin Invest (1946) 3.88

Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84

Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63

INSECTS AND EPIDEMIOLOGY OF POLIOMYELITIS. Science (1942) 3.59

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56

FLIES AS CARRIERS OF POLIOMYELITIS VIRUS IN URBAN EPIDEMICS. Science (1941) 3.48

A multifactor complex of eukaryotic initiation factors, eIF1, eIF2, eIF3, eIF5, and initiator tRNA(Met) is an important translation initiation intermediate in vivo. Genes Dev (2000) 3.39

Related functional domains in virus DNA polymerases. EMBO J (1987) 3.35

Epithelial cell polarity and cell junctions in Drosophila. Annu Rev Genet (2001) 3.22

Complete mitochondrial genome sequences of two extinct moas clarify ratite evolution. Nature (2001) 3.12

The replication of bacteriophage phi X174 DNA in vitro. Temperature effects on repair synthesis and displacement synthesis. Biochim Biophys Acta (1971) 3.07

High resolution structures of HIV-1 RT from four RT-inhibitor complexes. Nat Struct Biol (1995) 3.04

POLIOMYELITIS VIRUS IN FLY-CONTAMINATED FOOD COLLECTED AT AN EPIDEMIC. Science (1945) 3.04

Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med (1996) 2.96

The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum (1999) 2.92

Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89

Improved out-of-hospital cardiac arrest survival through the inexpensive optimization of an existing defibrillation program: OPALS study phase II. Ontario Prehospital Advanced Life Support. JAMA (1999) 2.87

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80

THE NATURAL HISTORY OF HUMAN POLIOMYELITIS : I. DISTRIBUTION OF VIRUS IN NERVOUS AND NON-NERVOUS TISSUES. J Exp Med (1941) 2.68

Occupational asthma due to porcine pancreatic amylase. Occup Environ Med (1997) 2.62

NATURE OF NON-PARALYTIC AND TRANSITORY PARALYTIC POLIOMYELITIS IN RHESUS MONKEYS INOCULATED WITH HUMAN VIRUS. J Exp Med (1941) 2.54

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. Lancet (1990) 2.50

The effectiveness of exercise for the prevention and treatment of antenatal depression: systematic review with meta-analysis. BJOG (2014) 2.45

The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J Gen Virol (1989) 2.40

AIDS virus reverse transcriptase defined by high level expression in Escherichia coli. EMBO J (1987) 2.37

Development and mapping of microsatellite (SSR) markers in wheat. Theor Appl Genet (2005) 2.27

Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26

Estrogen hits the surface. Nat Med (1999) 2.24

Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24

Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis (2001) 2.23

mtDNA and the origin of the Icelanders: deciphering signals of recent population history. Am J Hum Genet (2000) 2.23

Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol (1989) 2.22

Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. Am J Hum Genet (2000) 2.22

Submillimetre galaxies reside in dark matter haloes with masses greater than 3 × 10(11) solar masses. Nature (2011) 2.21

Importance of carbon dioxide in the isolation of pneumococci. J Bacteriol (1966) 2.21

Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrob Agents Chemother (1980) 2.17

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci U S A (1992) 2.16

Direct measurement of attentional dwell time in human vision. Nature (1994) 2.15

The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol (1998) 2.10

Metastatic malignant mesothelioma presenting as colonic polyps. Hum Pathol (1997) 2.09

Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr (1997) 2.07

Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. J Gen Virol (1980) 2.07

Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat Med (1998) 2.07

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med (2007) 2.06

Multiple roles for the C-terminal domain of eIF5 in translation initiation complex assembly and GTPase activation. EMBO J (2001) 2.06

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature (1981) 2.03

Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. J Gen Virol (1980) 2.01

Mood, personality, and self-monitoring: negative affect and emotionality in relation to frontal lobe mechanisms of error monitoring. J Exp Psychol Gen (2000) 2.01

Relative potencies of anti-herpes compounds. Ann N Y Acad Sci (1977) 1.98

Restricted attentional capacity within but not between sensory modalities. Nature (1997) 1.96

Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet (2001) 1.91

Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase. Biochem J (1989) 1.89

The dependence of some strains of Mycobacterium avium on mycobactin for initial and subsequent growth. J Med Microbiol (1978) 1.86

Micro-organisms in gastroenteritis. Arch Dis Child (1984) 1.86

The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent. J Antimicrob Chemother (1979) 1.85

Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature (1995) 1.85

Competitive brain activity in visual attention. Curr Opin Neurobiol (1997) 1.84

Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex (2001) 1.83

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81

mtDna and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry. Am J Hum Genet (2001) 1.81

Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia (2010) 1.77

A survey of the intended management of acute postoperative pain by newly qualified doctors in the south west region of England in August 1992. Anaesthesia (1994) 1.74

The multifunctional folic acid synthesis fas gene of Pneumocystis carinii appears to encode dihydropteroate synthase and hydroxymethyldihydropterin pyrophosphokinase. Gene (1992) 1.74

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost (2012) 1.74

The Ontario Prehospital Advanced Life Support (OPALS) Study: rationale and methodology for cardiac arrest patients. Ann Emerg Med (1998) 1.73

The pathogenicity of Mycobacterium avium and related mycobacteria for experimental animals. J Med Microbiol (1983) 1.72

Modifiable factors associated with improved cardiac arrest survival in a multicenter basic life support/defibrillation system: OPALS Study Phase I results. Ontario Prehospital Advanced Life Support. Ann Emerg Med (1999) 1.71

6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci (1994) 1.70

Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA. Cell (1978) 1.69

The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology (1999) 1.68

Factors associated with early failure of arteriovenous fistulae for haemodialysis access. Eur J Vasc Endovasc Surg (1996) 1.65

Hormone replacement therapy and the cardiovascular system. Nonlipid effects. Drugs (1994) 1.61

Cervical epidural steroid injection with intrinsic spinal cord damage. Two case reports. Spine (Phila Pa 1976) (1998) 1.61

Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61

Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) (2005) 1.59

Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) (1983) 1.58

Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation (1999) 1.58

The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res (2000) 1.55

Actin. Protein Profile (1995) 1.55

Surgical correction of hypotropias associated with thyroid dysfunction. Arch Ophthalmol (1965) 1.51

Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50

Plant-derived estrogens relax coronary arteries in vitro by a calcium antagonistic mechanism. J Am Coll Cardiol (2000) 1.50

First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50

Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. J Autoimmun (1988) 1.49

POLIOMYELITIS IN A LABORATORY WORKER EXPOSED TO THE VIRUS. Science (1941) 1.48

The role of plasminogen activators in the regulation of connective tissue metalloproteinases. Ann N Y Acad Sci (1992) 1.48

Experimental infection studies of UK Culicoides species midges with bluetongue virus serotypes 8 and 9. Vet Rec (2008) 1.47

Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J (1996) 1.46

Esterified estrogens combined with methyltestosterone improve emotional well-being in postmenopausal women with chest pain and normal coronary angiograms. Menopause (2001) 1.45